| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | GH Guardant Health, INC. | Monroe Terilyn J. | Chief People Officer | Sell | 36,591 | $106.30 | $3,889,553.41 | -19.3% | - | - | |
| Dec 1, 2025 | NTRA Natera, INC. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,750 | $238.19 | $655,015.52 | -0.8% | - | - | |
| Dec 1, 2025 | TMO Thermo Fisher Scientific INC. | Lowery Frederick M. | Executive Vice President | Sell | 6,913 | $597.68 | $4,131,761.84 | -32.5% | - | - | |
| Dec 1, 2025 | A Agilent Technologies, INC. | Dolsten Mikael | Director | Sell | 2,600 | $149.81 | $389,511.20 | -34.3% | - | - | |
| Dec 1, 2025 | NOTV Inotiv, INC. | Neff R Matthew | Director | Sell | 2,000 | $0.89 | $1,770.60 | -1.3% | - | - | |
| Dec 1, 2025 | NTRA Natera, INC. | Chapman Steven Leonard | CEO And President | Sell | 3,444 | $237.69 | $818,600.08 | -1.2% | - | - | |
| Dec 1, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 23,178 | $593.25 | $13,750,348.50 | -3.4% | - | - | |
| Dec 1, 2025 | WGS Genedx Holdings CORP. | Feeley Kevin | Chief Financial Officer | Sell | 377 | $162.54 | $61,276.07 | -8.2% | - | - | |
| Nov 28, 2025 | FLGT Fulgent Genetics, INC. | Xie Jian | President And COO | Sell | 1,198 | $29.57 | $35,424.26 | -0.4% | - | - | |
| Nov 28, 2025 | FLGT Fulgent Genetics, INC. | Gao Hanlin | Chief Scientific Officer | Sell | 943 | $29.57 | $27,884.04 | - | - | - | |
| Nov 28, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 56,482 | $603.28 | $34,074,469.74 | -4.0% | - | - | |
| Nov 26, 2025 | A Agilent Technologies, INC. | Gonsalves Rodney | V.p., Corporate Controller | Sell | 3,000 | $154.99 | $464,955.90 | -8.6% | - | - | |
| Nov 26, 2025 | CSTL Castle Biosciences INC | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 4,258 | $40.09 | $170,703.22 | -9.3% | - | - | |
| Nov 25, 2025 | DHR Danaher CORP /de/ | Rales Mitchell P | Chairman Of Exec. Committee | Sell | 40,625 | $230.38 | $9,359,066.67 | -2.3% | - | - | |
| Nov 25, 2025 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc | Head Of Eur &Na Market Orgs | Sell | 3,580 | $1,480.00 | $5,298,400.00 | -57.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.